The pharmaceutical industry and life science are more and more focusing on state-of-the-art technologies based on advanced pharma data analysis. We live in the post-data era – the time, when huge amounts of data have been already produced and the current task is to process them for a more accurate perception of the pharmaceutical market, as well as companies’ internal processes and ongoing clinical trials.

 Utilization of advanced tools, such as BI services, Artificial Intelligence or Augmented Analytics in pharma is the key to success in this business which is basically based on the data generation.


Business Intelligence solutions and Pharma Analytics systems are actively applied by pharma companies to better harness valuable data, identifying the most suitable candidates for potential drugs. 

According to the Worldwide Health Industry 2020 Predictions report, IDC professionals claim that the next decade will be defined by healthcare data and the technologies needed to harness them.

Accenture and IDC Health Insights conducted a survey across 126 pharmaceutical and biotechnology leading companies from the United States and the United Kingdom and found out that most surveyed enterprises have a strong consensus about the importance of data.

BI for Data Analysis: Applications in Pharma


Developing a pharmaceutical product requires a lot of effort, which self-evidently entails many challenges. The major of them are related to constantly produced data. 

Patient-driven healthcare 

The influx of data generated by consumer-based health devices, namely wearable gadgets allows drug companies to directly collaborate with customers, receiving from them important data related to reactions to particular drug elements or general health conditions. However, to gain these insights, pharmaceutical companies need to process and analyze huge amounts of constantly growing data in real-time. 

Past Clinical Trials 

Results of past clinical trials and tests are very important for ongoing and future ones. However, to comb through in order to find valuable insight into patients’ reactions to a particular drug, adverse effects they might experience or the number of patients enrolled in the trial – is a very challenging and difficult process, especially when performed manually. 

Outpacing Rivals

Before releasing a new drug product or pharmaceutical research,  companies need to be aware of the market situation in their sphere / However, the challenging part lies in the fact that the pharmaceutical companies constantly release new products and perform new trials, which are difficult to keep track. The answer is Business Intelligence.



Business Intelligence (BI) software is a new cutting-edge pharma big data solution that provides a real-time data analysis based on numerous internal and external sources. The extracted information is then visualized in an interactive way through charts, diagrams, and graphics. 

Big Data refers to a large number of both structured and unstructured data. McKinsey defines it as “datasets whose size is beyond the ability of typical database software tools to capture, store, manage, and analyze”.

According to the McKinsey Global Institute:

“…applying big-data strategies to better inform decision making could generate up to $100 billion in value annually across the US health-care system, by optimizing innovation, improving the efficiency of research and clinical trials, and building new tools for physicians, consumers, insurers, and regulators to meet the promise of more individualized approaches.”

The Pharmaceutical Business Intelligence (BI) solution is designed to gather, evaluate, and compare pharma data from multiple sources, allowing companies to operate more efficiently, improve employee productivity, increase revenue as well as enhance their competitive edge. The applications of BI solutions in the pharma industry are far-reaching. 

Applications of business analytics and business intelligence solutions

Applications of business analytics and business intelligence solutions

Operational Processes 

The value of Big Data and advanced pharma analytics solutions allow pharmaceutical enterprises to gain a better view across their vast network. Tracking and analyzing data from supply networks, production levels, and financial transactions allows enterprises to avoid pitfalls and promptly handle occurring problems and challenges. Moreover, BI systems eliminate the need of interdependency within various departments and make it easy for them to retrieve information whenever needed. Users can view and manage data in a simple dashboard environment, which is interactive and easy-to-understand. 

Marketing and Sales 

With BI software, pharmaceutical companies can efficiently track sales performance and consumer behavior in order to control and improve their marketing and sales strategies. BI systems proceed external data about the market, competitors, advertising campaigns as well as efficiently evaluate current trends, market share, revenues, and sales performance. Moreover, this Pharma-Data- powered software can efficiently analyze how fresh products are performing in the market and, so that companies can take needed measures to boost their market share. By having a better view across the entire industry pharmaceutical companies applying BI solutions enhance their marketing and sales performance. 

Research and Development 

In a world, where “big pharma” and “big tech” collide, new opportunities emerge. With the advance of business analytics technology, the pharmaceutical research and development (R&D) processes are getting to a new level where data becomes the key to more effective and innovative trials and research. With the ability of BI to analyze a huge amounts of structured and unstructured data, visualize processed information, and even make predictions, the pharma industry will create a lot of value from the enhanced use of Big Data and reach a higher level of productivity. 

As McKinsey claims in its report

“Pharmaceutical R&D suffers from declining success rates and a stagnant pipeline. Big data and the analytics that go with it could be a key element of the cure.”

The pharmaceutical R&D can use BI tools in three ways: analysis of past trials, support for current clinical trials, and predictive modeling.  BI can handle and visualize the existing results and all available information about past trials, that can be useful for current or future ones. BI software also uses operational data from clinical trials for similar drugs or similar practices.

On the basis of patients’ genetic data, a BI-driven program can evaluate the risks involved with certain patients. Another area where BI proves its effectiveness is predictive modeling. An advanced BI can predict patients’ likelihood to respond to particular drugs, forecast their adverse effects, as well as recommend the needed number of people to be enrolled with a trial. 



  • Market analysis 

Provided by BI, market analysis proceeds external market data from Insight Health, IMS, WHO as well as data from various internet sources in order to provide pharmaceutical companies with a better view of the entire industry. 

  • Sales analysis 

Sales analysis encompasses sales performance monitoring and consumer behavior tracking in order to identify seasonal demand, slow-moving products, outliers, and much more.

  • Marketing analysis 

BI marketing analysis helps companies to get a better view of the effectiveness of their marketing campaigns. 

  • Financial analysis 

Analyzing and then visualizing financial information allows pharmaceutical companies to maintain expenses and create efficient.

  • Operational analysis 

Operational analysis enables pharma companies to get valuable information on business operations. BI software can identify general areas that companies need to improve.

  • Clinical Data Analysis 

Clinical Data Analysis works with available information from clinical trials, extracting valuable insights, and visualizing them in an interactive way.

  • Regulatory analysis 

By constantly tracking regulatory compliance the BI regulatory analysis helps pharmaceutical companies to adhere to certain regulatory requirements, for instance, HIPAA. 


BI Services for the Operational Analysis Case

Using a Power BI tool Softengi has helped MicroTechniX, a company specialized in the automation of laboratory processes, to visualize their product usage based on the company database. The BI system on par with pharma analytics provides all information in the form of diagrams and graphs, thus facilitating the process of comprehension. The Power BI tool enabled the system to automatically update reports if something is altered in the database. 

The Softengi BI system regularly generates seven reports for MicroTechniX in different areas of business. In particular, the software visualizes how many unique users have accessed the product or how many new users have emerged a day. As a result, the company more clearly monitors its internal and external business processes. 

BI Services for the Operational Analysis Case

Final worlds…

The key to company success in the pharma industry is efficient utilization of Big Data. A Business Intelligence solution can efficiently process and analyze pharma data, providing insights with in-depth analytical reports, interactive dashboards, and user-friendly graphs.

In order to successfully implement a business intelligence system, a company needs to approach an experienced IT vendor. Softengi, with its high experience in Big Data, Business Intelligence, and Artificial Intelligence, enables companies to efficiently handle pharma data from multiple sources, transforming analyzed information into valuable knowledge. 


Send your message

    Call back request

    Contact Us

    Paul, Head of International Sales       

    P: +1 (202) 7889535

    e-mail:  [email protected]

    Book time slot

    Robert, US Representative, СRO

    e-mail:  [email protected]

    Book time slot